Related references
Note: Only part of the references are listed.Cardiac glycosides regulate endothelial tissue factor expression in culture
Barbara E. Staehli et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Expression, localization and tau exon 10 splicing activity of the brain RNA-binding protein TNRC4
J. Paul Chapple et al.
HUMAN MOLECULAR GENETICS (2007)
Splicing in disease: disruption of the splicing code and the decoding machinery
Guey-Shin Wang et al.
NATURE REVIEWS GENETICS (2007)
Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth
Wilhelm Schoner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsense-mediated decay
Julie Z. Ni et al.
GENES & DEVELOPMENT (2007)
Signals, pathways and splicing regulation
Matias Blaustein et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
New roles for an old enzyme: Na,K-ATPase emerges as an interesting drug target
A. Aperia
JOURNAL OF INTERNAL MEDICINE (2007)
SR protein 9G8 modulates splicing of tau exon 10 via its proximal downstream intron, a clustering region for frontotemporal dementia mutations
Lei Gao et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2007)
A bichromatic fluorescent reporter for cell-based screens of alternative splicing
James P. Orengo et al.
NUCLEIC ACIDS RESEARCH (2006)
SRp54 (SFRS11), a regulator for tau exon 10 alternative splicing identified by an expression cloning strategy
Jane Y. Wu et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Identification of RNA-binding proteins that regulate FGFR2 splicing through the use of sensitive and specific dual color fluorescence minigene assays
Emily A. Newman et al.
RNA (2006)
Use of transcriptional synergy to augment sensitivity of a splicing reporter assay
N Levinson et al.
RNA (2006)
Arginine/serine-rich protein interaction domain-dependent modulation of a tau Exon 10 splicing enhancer -: Altered interactions and mechanisms for functionally antagonistic FTDP-17 mutations Δ280K and N279K
I D'Souza et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors
J Soret et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Tau exons 2 and 10, which are misregulated in neurodegenerative diseases, are partly regulated by silencers which bind a SRp30c•SRp55 complex that either recruits or antagonizes htra2β1
YZ Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Regulation of tau isoform expression and dementia
I D'Souza et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Increased noncanonical splicing of autoantigen transcripts provides the structural basis for expression of untolerized epitopes
B Ng et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Pre-mRNA splicing and human disease
NA Faustino et al.
GENES & DEVELOPMENT (2003)
Signals and their transduction pathways regulating alternative splicing: a new dimension of the human genome
S Stamm
HUMAN MOLECULAR GENETICS (2002)
Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients
C Andreassi et al.
HUMAN MOLECULAR GENETICS (2001)
An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA
ML Zhang et al.
GENE THERAPY (2001)
Treatment of spinal muscular atrophy by sodium butyrate
JG Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
